Inventor · disambiguated record
Richard E. Lee
Also filed as: LEE RICHARD · LEE RICHARD E · LEE RICHARD EDWARD · LEE RICHARD T
20 granted patents·15 pending applications·58 citations·filing 2001–2024
93Inventor score
Files withST JUDE CHILDRENS RES HOSPITAL7ST JUDE CHILDRENS RES HOSPITAL INC6ASTRAZENECA AB4UNIV TENNESSEE RES FOUNDATION3LEE RICHARD E2
Top patents by PatentIndex Score
35 records- 0190US7456222B2Anti tubercular drug: compositions and methodsSEQUELLA INC·Filed 2005·Granted Nov 25, 2008·15 cites·27 claims
- 0284US10899734B2Small molecule modulators of pantothenate kinasesST JUDE CHILDRENS RES HOSPITAL·Filed 2017·Granted Jan 26, 2021·4 cites·16 claims
- 0383US11547709B2Methods of treating disorders associated with castorST JUDE CHILDRENS RES HOSPITAL INC·Filed 2018·Granted Jan 10, 2023·2 cites·19 claims
- 0483US7842729B2Anti tubercular drug: compositions and methodsUS HEALTH·Filed 2005·Granted Nov 30, 2010·6 cites·24 claims
- 0582US12115225B2GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereofASTRAZENECA AB·Filed 2021·Granted Oct 15, 2024·1 cites·12 claims
- 0681US11891378B2Small molecule modulators of pantothenate kinasesST JUDE CHILDRENS RES HOSPITAL INC·Filed 2018·Granted Feb 6, 2024·2 cites·3 claims
- 0780US10822377B2Substituted urea depsipeptide analogs as activators of the ClpP endopeptidaseST JUDE CHILDRENS RES HOSPITAL·Filed 2019·Granted Nov 3, 2020·1 cites·18 claims
- 0878US6951961B2Methods of use and compositions for the diagnosis and treatment of infectious diseasePROTOPOPOVA MARINA NIKOLAEVNA·Filed 2002·Granted Oct 4, 2005·12 cites·79 claims
- 0976US10100090B2Substituted urea depsipeptide analogs as activators of the CLPP endopeptidaseST JUDE CHILDRENS RES HOSPITAL·Filed 2016·Granted Oct 16, 2018·2 cites·20 claims
- 1076US9879050B2Substituted urea depsipeptide analogs as activators of the CLPP endopeptidaseST JUDE CHILDREN'S RES HOSPITAL·Filed 2014·Granted Jan 30, 2018·2 cites·20 claims
- 1173US2025090526A1Methods of treating disorders associated with castorST JUDE CHILDRENS RES HOSPITAL INC·Filed 2024·Application pending·0 cites
- 1272US10676510B2Substituted urea depsipeptide analogs as activators of the ClpP endopeptidaseST JUDE CHILDRENS RES HOSPITAL·Filed 2018·Granted Jun 9, 2020·1 cites·9 claims
- 1372US2024293563A1Glp-1 receptor ligand moiety conjugated oligonucleotides and uses thereofASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1471US10266544B2Aryl substituted aminomethyl spectinomycin analogs as antibacterial agentsST JUDE CHILDRENS RES HOSPITAL INC·Filed 2014·Granted Apr 23, 2019·4 cites·31 claims
- 1571US8685978B2Spectinamides as anti-tuberculosis agentsLEE RICHARD E·Filed 2010·Granted Apr 1, 2014·2 cites·24 claims
- 1669US2023321092A1Methods of treating disorders associated with castorST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Application pending·0 cites
- 1766US9593136B2Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomeraseBOSHOFF HELENA I·Filed 2012·Granted Mar 14, 2017·2 cites·9 claims
- 1865US8552208B2Analogs of tetramic acidLEE RICHARD E·Filed 2008·Granted Oct 8, 2013·2 cites·2 claims
- 1965US2025163075A1Heterobifunctional targeted protein degradersST JUDE CHILDRENS RES HOSPITAL·Filed 2024·Application pending·0 cites
- 2061US2020270311A1Substituted urea depsipeptide analogs as activators of the clpp endopeptidaseST JUDE CHILDREN'S HOSPITAL·Filed 2020·Application pending·0 cites
- 2156US9284325B2Spectinamides as anti-tuberculosis agentsUNIV TENNESSEE RES FOUNDATION·Filed 2014·Granted Mar 15, 2016·0 cites·45 claims
- 2256US2025327770A1Protein-Derived Peptide Multiplexes for Biomimetic Detection of VOC ProfilesUNIV WASHINGTON·Filed 2023·Application pending·0 cites
- 2355US10457707B2Substituted urea depsipeptide analogs as activators of the CLPP endopeptidaseST JUDE CHILDRENS RES HOSPITAL·Filed 2018·Granted Oct 29, 2019·0 cites·20 claims
- 2454US2005163811A1Topical solutions comprising high concentrations of piperidinopyrimidine derivatives and methods of use thereofFiled 2004·Application pending·0 cites
- 2552US2020268898A1Glp-1 receptor ligand moiety conjugated oligonucleotides and uses thereofASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 2651US8268894B2Compositions and methods for the treatment of infectious diseasesPROTOPOPOVA MARINA NIKOLAEVNA·Filed 2010·Granted Sep 18, 2012·0 cites·21 claims
- 2751US2004033986A1Anti tubercular drug: compositions and methodsFiled 2003·Application pending·0 cites
- 2851US2004019117A1Anti tubercular drug: compostions and methodsFiled 2003·Application pending·0 cites
- 2947US2021388012A1Methods and compositions for prodrug forms of spectinomycin and spectinamide analogsST JUDE CHILDRENS RES HOSPITAL INC·Filed 2018·Application pending·0 cites
- 3042US10570179B2Substituted urea depsipeptide analogs as activators of the CLPP endopeptidaseST JUDE CHILDRENS RES HOSPITAL·Filed 2017·Granted Feb 25, 2020·0 cites·20 claims
- 3141US2005026968A1Heterocyclic amides with anti-tuberculosis activityUNIV TENNESSEE RES FOUNDATION·Filed 2004·Application pending·0 cites
- 3241US2019134214A1GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses ThereofASTRAZENECA AB·Filed 2017·Application pending·0 cites
- 3339US10011589B2Treatments for gastrointestinal conditionsUNIV TEXAS·Filed 2015·Granted Jul 3, 2018·0 cites·12 claims
- 3438US2005222408A1Heterocyclic amides with anti-tuberculosis activityUNIV TENNESSEE RES FOUNDATION·Filed 2005·Application pending·0 cites
- 3535US2002115081A1Diagnosis and treatment of cardiovascular conditionsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard E. Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →